Xin Huang, Cunte Chen, Mengjun Zhong, Suxia Geng, Yujie Zhao, Minming Li, . . . Yangqiu Li. (2021). Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome. BMC.
Chicago Style (17th ed.) CitationXin Huang, et al. Lower BCL11B Expression Is Associated with Adverse Clinical Outcome for Patients with Myelodysplastic Syndrome. BMC, 2021.
MLA (9th ed.) CitationXin Huang, et al. Lower BCL11B Expression Is Associated with Adverse Clinical Outcome for Patients with Myelodysplastic Syndrome. BMC, 2021.
Warning: These citations may not always be 100% accurate.